Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apollomics
Biotech
Apollomics tags out of TYG oncology pact to cut costs
The termination forms part of the reevaluation of priorities at the cash-strapped biotech that played out across last year.
Nick Paul Taylor
Apr 4, 2025 6:45am
Apollomics sells Asia rights to c-MET inhibitor in $60M deal
Mar 31, 2025 9:44am
Apollomics, after giving up on leukemia drug, posts ph. 3 fail
Dec 20, 2024 9:30am
Apollomics execs lead job cuts as cancer biotech ekes out cash
Jul 3, 2024 8:44am
Apollomics is latest biotech to give SPACs a second chance
Sep 15, 2022 10:48am
